These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 313228

  • 1. Evidence that protease inhibitors reduce the degradation of parathyroid hormone and calcitonin injected subcutaneously.
    Parsons JA, Rafferty B, Stevenson RW, Zanelli JM.
    Br J Pharmacol; 1979 May; 66(1):25-32. PubMed ID: 313228
    [Abstract] [Full Text] [Related]

  • 2. The comparison of parathyroid hormone degradation effect by various protease inhibitors in blood specimen.
    Kim YS, Kwon HJ, Lee HK.
    Korean J Lab Med; 2009 Apr; 29(2):104-9. PubMed ID: 19411775
    [Abstract] [Full Text] [Related]

  • 3. Use of protease inhibitors to protect subcutaneously injected peptide hormones against local degradation [proceedings].
    Parsons JA, Rafferty B, Stevenson RW, Zanelli JM.
    Br J Pharmacol; 1977 Mar; 59(3):489P-490P. PubMed ID: 843728
    [No Abstract] [Full Text] [Related]

  • 4. A stimulation test with calcitonin for differential diagnosis of hypercalcaemia.
    Benson L, Wide L, Akerström G, Ljunghall S.
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):237-44. PubMed ID: 6495990
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM.
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [Abstract] [Full Text] [Related]

  • 6. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y, Jee WS, Chen Y, Gasser J, Ke HZ, Li XJ, Kimmel DB.
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [Abstract] [Full Text] [Related]

  • 7. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
    Chunxiao W, Jingjing L, Yire X, Min D, Zhaohui W, Gaofu Q, Xiangchun S, Xuejun W, Jie W, Taiming L.
    Regul Pept; 2007 Jun 07; 141(1-3):35-43. PubMed ID: 17300845
    [Abstract] [Full Text] [Related]

  • 8. Calcitonin and the bone fluid compartment: effect of calcitonin and/or parathyroid hormone on plasma radiocalcium changes.
    Dopplet SH, Talmage RV.
    Clin Orthop Relat Res; 1976 Jun 07; (118):242-50. PubMed ID: 954281
    [Abstract] [Full Text] [Related]

  • 9. The effect of different protease inhibitors on stability of parathyroid hormone, insulin, and prolactin levels under different lag times and storage conditions until analysis.
    Baykan O, Yaman A, Gerin F, Sirikci O, Haklar G.
    J Clin Lab Anal; 2017 Nov 07; 31(6):. PubMed ID: 28133791
    [Abstract] [Full Text] [Related]

  • 10. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
    DeLuca PP, Dani BA.
    AAPS PharmSci; 2001 Nov 07; 3(4):E27. PubMed ID: 12049490
    [Abstract] [Full Text] [Related]

  • 11. A dual effect of calcitonin gene-related peptide on plasma calcium levels in the chick.
    Bevis PJ, Zaidi M, MacIntyre I.
    Biochem Biophys Res Commun; 1990 Jun 29; 169(3):846-50. PubMed ID: 2363727
    [Abstract] [Full Text] [Related]

  • 12. Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D.
    Naveh-Many T, Friedlaender MM, Mayer H, Silver J.
    Endocrinology; 1989 Jul 29; 125(1):275-80. PubMed ID: 2737148
    [Abstract] [Full Text] [Related]

  • 13. Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: implications in peptide delivery to the colon.
    Tozaki H, Emi Y, Horisaka E, Fujita T, Yamamoto A, Muranishi S.
    J Pharm Pharmacol; 1997 Feb 29; 49(2):164-8. PubMed ID: 9055189
    [Abstract] [Full Text] [Related]

  • 14. Renal parathyroid hormone receptors in the chick: downregulation in secondary hyperparathyroid animal models.
    Forte LR, Langeluttig SG, Poelling RE, Thomas ML.
    Am J Physiol; 1982 Mar 29; 242(3):E154-63. PubMed ID: 6278948
    [Abstract] [Full Text] [Related]

  • 15. Environmental Factors That Affect Parathyroid Hormone and Calcitonin Levels.
    Babić Leko M, Pleić N, Gunjača I, Zemunik T.
    Int J Mol Sci; 2021 Dec 21; 23(1):. PubMed ID: 35008468
    [Abstract] [Full Text] [Related]

  • 16. [Parathyroid hormone and calcitonin].
    Yasutomo Y, Nagata N.
    Nihon Rinsho; 1992 Dec 21; 50(12):2925-30. PubMed ID: 1337117
    [Abstract] [Full Text] [Related]

  • 17. Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone.
    Anderson NR, Nicholas J, Holland MR, Gama R.
    Ann Clin Biochem; 2003 Mar 21; 40(Pt 2):188-90. PubMed ID: 12662411
    [Abstract] [Full Text] [Related]

  • 18. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
    Gautvik KM, Gordeladze JO, Moxheim E, Gautvik VT.
    Eur Surg Res; 1984 Mar 21; 16 Suppl 2():41-54. PubMed ID: 6723731
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 21; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone degradation by chymotrypsin-like endopeptidase in the opossum kidney cell.
    Yamaguchi T, Fukase M, Nishikawa M, Fujimi T, Fujita T.
    Endocrinology; 1988 Dec 21; 123(6):2812-7. PubMed ID: 3058460
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.